Aurinia Pharmaceuticals Inc (AUPH)

12.64
-0.22(-1.71%)
After Hours
12.72
+0.08(+0.63%)
- Real-time Data
  • Volume:
    1,643,391
  • Bid/Ask:
    12.64/12.72
  • Day's Range:
    12.54 - 12.94

AUPH Overview

Prev. Close
12.86
Day's Range
12.54-12.94
Revenue
51.09M
Open
12.87
52 wk Range
9.74-20.42
EPS
-
Volume
1,643,391
Market Cap
1.68B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,615,006
P/E Ratio
-
Beta
-
1-Year Change
-17.09%
Shares Outstanding
-
Next Earnings Date
Aug 12, 2021
What is your sentiment on Aurinia Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Aurinia Pharmaceuticals Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellStrong SellSell
Technical IndicatorsBuyStrong SellStrong SellSellStrong Sell
SummaryNeutralStrong SellStrong SellStrong SellStrong Sell

Aurinia Pharmaceuticals Inc Company Profile

Aurinia Pharmaceuticals Inc Company Profile

Industry
-
Sector
-
Employees
0

  • beautiful!
    0
    • AUPH reported positive data as competitors 'stumble,' says H.C. Wainwright analyst Ed Arce noted that (AUPH) announced that a "supportive interim analysis" of its AURORA 2 study will be presented at EULAR, held June 2-5. The new data will represent the longest-available outcomes data for LUPKYNIS to date for the treatment of lupus nephritis, or LN, said Arce. Meanwhile, competitor Boehringer Ingelheim announced in a poster presentation at EULAR that its anti-CD40 mAb, BI655064, failed to meet its primary endpoint of complete renal response and Eli Lilly (LLY) disclosed in a recent quarterly filing that TULIP-LN1, its Phase 2 study of anifrolumab, also failed to meet its primary endpoint, according to Arce. The analyst, who maintains his 100% odds of approval view for LUPKYNIS in the U.S., keeps a Buy rating and $35 price target on Aurinia shares. AUPH LLY
      0
      • oh she is showing some life! Go Aurinia
        0
        • Turning point is 12.50-60 , buy heavy.
          0
          • What time earnings news tomorrow?
            0
            • Keep sliding after fda approval
              1
              • What is going on? No news, hugh drop this morning. Should I double down?
                2
                • nothing happened After FDA approuval, which was the main Catalyst... so I dont know...
                  0
              • good move, but I wouldve expect a better run up After the FDA approuval
                0
                • Lot of FOMO!!
                  5
                  • trading on AUPH is suspended. Most likely merger or buyout in the works. doubtful it will continue trading until market opens
                    0
                    • Trading doesn't happen on Weekends dude!
                      0
                    • My bad I see. But definitely status would change to Open on Monday.
                      0
                  • Fda approved!
                    0
                    • Joe, add prvb to your watchlist.
                      0
                      • Sure, get in lower. Buy the rumor, sale the news. Most likely anxiety trading until news comes out than it go one way for awhile.
                        0
                        • i closed my positions at the opening. do you recommand to buy again?
                          0
                          • Howd you do?
                            0
                        • and now back in the green...can you please explain?
                          0
                          • Expecting fda approval today. Some will take some off the table until the news is out.
                            1
                          • in fact i have closed my positions at the opening
                            1
                          • do you recommand to buy again?
                            0
                        • what happen is crasy...ut went +14% in the premarket..and at the opening dropped to -2%
                          0
                          • Fda approval tomorrow... big bucks no whammies!!!!
                            0
                            • whats happening here
                              0
                              • https://pipelinereview.com/index.php/2020110376390/Proteins-and-Peptides/Aurinia-Announces-Outcome-of-AUDREY-Clinical-Trial-in-Dry-Eye-Syndrome.html
                                0
                              • https://pipelinereview.com/index.php/2020110376390/Proteins-and-Peptides/Aurinia-Announces-Outcome-of-AUDREY-Clinical-Trial-in-Dry-Eye-Syndrome.html
                                0
                            • Can Reach 25 soon. India found tablets for vorona. Aurinia i think has direct tie up with them.
                              0
                              • Resistance is futile! Keep going!
                                0
                                • when is the fda going to decide whether or not to approve voclosporin? also, how long is aiph stock going to remain sluggish?
                                  0
                                  • Sluggish?? It's up 150% in less than a month. Aurinia will submit to FDA in "1H 2020", so approval within a year, hopefully.
                                    0
                                • Loooooong consolidation paid off
                                  0
                                  • I’m out to get back in another day... see ya at the aupport.
                                    0
                                  • Did the same. Feel like a few steps back, in the short term, is much more likely than breaking past 20.
                                    0
                                • Its time to short it though
                                  3
                                  • firas Kassemyou are right because i have read that aurinia will more than likely execute a second offering of common stock to raise more financial capital.
                                    0
                                  • Doesnt it seem like the offering made a posotive impact instead? May be worth watchinv until the 12th IMO
                                    0
                                  • You will regret it...
                                    1
                                • is aurinia pharma's stock price going to increase or decrease today?
                                  0
                                  • Increase :D
                                    0
                                • this aged well
                                  0
                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.